Ireland Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy), By Region, Competition, Forecast and Opportunities 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIreland Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy), By Region, Competition, Forecast and Opportunities 2028
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 2600.01 Million |
| CAGR (2023-2028) | 7.63% |
| Fastest Growing Segment | Oncology |
| Largest Market | Dublin |
For instance, according to the research article, in 2020, the value of pharmaceutical sales in Ireland increased by 52.4 million euros (+2.18%) since 2019.
One of the key drivers of growth in the Ireland pharmaceutical market is aging population. As people get older, they are more likely to require medication to treat chronic conditions such as diabetes, cardiac arrest, and arthritis. This has led to an increase in demand for medications and has created a large and growing market for pharmaceutical companies. Another factor driving growth in the Ireland pharmaceutical market is increasing healthcare spending. According to the World Bank, in 2020 Ireland spent €26.5bn on their healthcare infrastructure, equivalent to 7.1% of GDP. This was an 11.3% increase over the level of spending in 2019, which is explained by the additional costs due to COVID-19. The government has made healthcare a priority and has allocated significant resources to improving healthcare infrastructure and services. This has created a favorable environment for pharmaceutical companies, with a growing demand for drugs and therapies.
Additionally, the market growth can be attributed to the expanding healthcare infrastructure in the country and high investments by market players in developing effective drugs and medications, infectious disorders brought on by increased tourism, and environmental factors etc. is expected to drive the growth of the Ireland pharmaceuticals market.
Furthermore, the consistent research and technological advancement in the manufacturing of drugs and is expected to aid the growth of the Ireland pharmaceuticals market in the forecast period, 2024-2028. Moreover, the government supports the idea by increasing investment in the pharmaceutical sector and the pharmaceutical companies are forced to manufacture pharmaceuticals products in the country to bolster the growth of Ireland pharmaceuticals market.
. According to the research articles, health experts say at least 50 percent of heart attack patients in the Ireland are under the age of 50
The pharmaceutical industry is an important sector in Ireland, with a long history of success in the development and production of high-quality drugs. The sector has played a significant role in the Irish economy for many years, providing jobs and contributing to the country's GDP.
Ireland’s government is actively focused on developing the technology and the advancement in the pharmaceutical industry. Several initiatives were taken within the country therefore, they are focused towards developing the pharmaceutical industry due to its future growth prospects, export potential, and mid-term to long-term economic impact. In the recent years, majorly the pharmaceutical demands were fulfilled by imported drugs and products. Therefore, the market players tried to increase their manufacturing of pharmaceutical products, thereby initiating to strengthen bonds with multinational market players. Government is preparing favorable schemes and plans for the distribution channels and funding strategic location and sophisticated logistics infrastructure is anticipated to further strengthen the growth of the Ireland pharmaceutical market in the future five years.
Favorable Regulatory Environment
Market Segmentation
Download Free Sample Report
,
| Attribute | Details |
| Base Year | 2022 |
| Historical Years | 2018 – 2022 |
| Estimated Year | 2023E |
| Forecast Period | 2024F – 2028F |
| Quantitative Units | Revenue in USD Million, Volume in Units and CAGR for 2018-2023 and 2024E-2028F |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Drug Type Product Type Application Distribution Channel Region Company |
| Region Scope | Abu Dhabi, Dubai, Sharjah, and Rest of UAE |
| Key Companies Profiled | Roche Ireland, Novartis Ireland, Ireland GlaxoSmithKline, Pfizer Ireland, AstraZeneca Ireland, Johnson & Johnson Ireland Limited, Sanofi Aventis Ireland Ltd., Eli Lilly & Co (Ireland) Ltd, AbbVie Ireland, Takeda Pharmaceuticals Ireland Limited |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy